Skip to main navigation
Skip to content
Skip to content
PDL Logo Blue Green
  • About PDL
  • Leadership
  • Investor Relations
  • About PDL
    • Management
  • Portfolio of Assets
  • Investor Relations
  • News
  • Contact

POS AM

PDL  > Investor Relations > POS AM

SEC Filing Details

Document Details

Form
POS AM
Filing Date
Feb 2, 2021
Document Date
Feb 2, 2021
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
PDL BioPharma, Inc.
Issuer
PDL BIOPHARMA, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

    Investor Relations

    • Frequently Asked Questions (FAQ)
    • Investor Updates
    • Press Releases
    • 2020 Proxy Statement
    • Tax Information
      • Common Stock Tax Information
      • Convertible Note Tax Information
    • SEC Filings
    • Contact Information

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • RSS
    • Print
    • Share
    • Search
    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

PDL Logo White Fill

  • Terms of Use
  • Sitemap
© Copyright 2021 PDL BioPHARMA. All Rights Reserved.